The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process to revise the following ...
Mainstream economists are at a loss to explain why the current regime of inflation and central bank interventions have been ...
This note argues that the monetary disequilibrium framework mistakes frustrated plans for genuine market disequilibrium (in the sense of a lack of market clearing) and that these frustrated plans are ...
An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...
Diamyd Medical's registrational Phase 3 trial in type 1 diabetes, has now exceeded 290, and the screening will conclude in the coming weeks. The interim ...
Multiple teams have used powerful imaging, targeted placebo experiments, and AI to map and understand the brainstem’s pain ...
Discover why CoreWeave, Inc. remains a Strong Buy despite setbacks. Explore AI-driven growth, positive catalysts, and >26% ...
Vividly imagining a positive interaction with someone can increase how much you like them — and even alter how your brain stores information about that person.
On this "Face the Nation with Margaret Brennan" broadcast, Treasury Secretary Scott Bessent and Rep. Ilhan Omar join Margaret ...
In this article, we will take a look at the top 7 hidden multibagger stocks to invest in. Multibaggers often take the ...
Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback